PT092 - REASSURE observational study of radium-223 (Ra-223): First interim results by prior/concomitant treatment (Tx) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) enrolled in Europe
Autor: | Logue, J., Schostak, M., Baldari, S., Schrijvers, D., Sandzén, J., Meidahl Petersen, P., Procopio, G., Strauß, A., Borrega, P., Rebmann, U., Miller, K., Kalinovský, J., De Sanctis, Y., Sternberg, C., Tombal, B. |
---|---|
Zdroj: | In European Urology Supplements March 2018 17(2):e1855-e1856 |
Databáze: | ScienceDirect |
Externí odkaz: |